Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by RrPpMmSson Sep 28, 2018 9:37pm
204 Views
Post# 28713431

RE:Allow me connect the dots..............

RE:Allow me connect the dots..............again, what Prof Corn On Cob conveniently omitted is  NASDAQ also requires independent Director
also,in if Diageo moves on APH., are they then non-independent Directors ?!

So to Canadian exchanges, but we all knew that ..

The SEC staff frequently comments during its review process about the lack of an established corporate governance structure, such as board member independence and board committee composition, by OTC quoted issuers, even if not required by SEC and national securities exchange rules.

The SEC staff has regularly prioritized its review of corporate governance disclosure in registration statements, proxy statements and periodic reports. Much of this required disclosure, especially with regard to board member independence and board committee composition, is effectuated through the rules of national securities exchanges, namely the NYSE and Nasdaq, as a result of the Sarbanes-Oxley Act of 2002. Companies whose shares are quoted in the over-the-counter market, however, are not required to comply with the same national securities exchange rules as are NYSE and Nasdaq traded companies. Regardless, OTC quoted companies (e.g., companies whose shares are listed on the OTC Market Group's OTCQB or Pink marketplace) should be aware that the SEC
wants to know how and why they do or don’t meet NYSE/Nasdaq-level corporate governance standards.

Aside from Item 407(a) of Regulation S-K, which requires issuers to explain how they define
“independence”   .......


=+=+=+=+=+
ProfCornelius -
(9/28/2018 9:00:26 PM)


In one of Aphria's latest sedar document you will notice that a number of independent directors have been nominated to Aphria's board of directors.

The reason for this is quite simple....It is an NYSE requirement for a listed company to have independent directors! B I N G O #dotsconnected

Allow me connect the dots.......................
In one of Aphria's latest sedar document you will notice that a number of independent directors have been nominated to Aphria's board of directors.

The reason for this is quite simple....It is an NYSE requirement for a listed company to have independent directors! B I N G O #dotsconnected
Bullboard Posts